Financials in USD. Standardized financial statements.
A compact view of how Vext Science, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $52.27M | $36.00M | $34.81M | $35.41M | $37.24M | $25.19M | $22.32M | $18.48M | $14.85M |
| Revenue Growth? | +45.2% | +3.4% | -1.7% | -4.9% | +47.8% | +12.9% | +20.8% | +24.4% | 0.0% |
| Cost of Revenue? | $49.95M | $27.02M | $22.77M | $12.31M | $18.56M | $13.99M | $12.26M | $8.82M | $6.22M |
| Gross Profit? | $2.32M | $8.98M | $12.04M | $23.10M | $18.69M | $11.20M | $10.07M | $9.65M | $8.63M |
| Gross Margin? | +4.4% | +24.9% | +34.6% | +65.2% | +50.2% | +44.5% | +45.1% | +52.3% | +58.1% |
| Operating Expenses? | $11.67M | $20.16M | $13.84M | $13.82M | $9.47M | $7.84M | $6.48M | $4.03M | $2.91M |
| Operating Income? | -$9.35M | -$11.18M | -$1.80M | $8.93M | $9.49M | $3.22M | $3.59M | $5.58M | $5.64M |
| EBITDA? | $6.80M | -$2.02M | $17.36M | $15.03M | $12.80M | $5.52M | $4.67M | $5.58M | $6.13M |
| Income Before Tax | -$15.48M | -$21.12M | $3.36M | $6.70M | $6.82M | $2.64M | $3.67M | $4.88M | $5.64M |
| Income Tax Expense | $2.83M | $1.31M | -$1.04M | -$4.22M | $1.83M | $514,000 | $874,905 | $1.13M | $1.53M |
| Net Income? | -$18.31M | -$22.44M | $4.40M | $10.92M | $4.99M | $2.13M | $2.79M | $3.75M | $4.11M |
| EPS? | $-0.07 | $-0.09 | $0.03 | $0.08 | $0.04 | $0.02 | $0.03 | $0.05 | $0.06 |
| Diluted EPS? | $-0.07 | $-0.09 | $0.03 | $0.08 | $0.03 | $0.02 | $0.03 | $0.05 | $0.06 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality